HDAC9

histone deacetylase 9, the group of Histone deacetylases, class IIA

Basic information

Region (hg38): 7:18086949-19002416

Links

ENSG00000048052NCBI:9734OMIM:606543HGNC:14065Uniprot:Q9UKV0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Auriculocondylar syndrome 4 ADAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Craniofacial34750192

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HDAC9 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HDAC9 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
4
clinvar
6
missense
36
clinvar
1
clinvar
2
clinvar
39
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
2
clinvar
2
Total 0 0 37 3 8

Variants in HDAC9

This is a list of pathogenic ClinVar variants found in the HDAC9 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-18458861-A-G Likely benign (Jun 01, 2022)2657331
7-18496317-C-G not specified Uncertain significance (Aug 26, 2022)2400233
7-18585340-A-G not specified Uncertain significance (Apr 19, 2024)3283716
7-18585364-G-A not specified Uncertain significance (Sep 06, 2022)2393921
7-18590357-A-G not specified Uncertain significance (Oct 22, 2021)2363772
7-18590386-G-C not specified Uncertain significance (Jan 26, 2022)2383716
7-18590439-G-C not specified Uncertain significance (Aug 02, 2022)2304667
7-18591587-A-G not specified Uncertain significance (Feb 07, 2023)2482090
7-18591594-C-G Likely benign (Apr 24, 2018)716079
7-18591624-A-G not specified Uncertain significance (Mar 18, 2024)3283713
7-18591652-G-A Benign (Dec 31, 2019)770372
7-18629397-G-A not specified Uncertain significance (Oct 25, 2022)2214389
7-18629459-G-C not specified Uncertain significance (Jan 08, 2024)3104655
7-18634659-G-T not specified Uncertain significance (Aug 30, 2021)2247576
7-18634723-C-T not specified Uncertain significance (Aug 10, 2021)2375896
7-18634740-G-A not specified Uncertain significance (May 09, 2023)2514246
7-18644713-A-G not specified Uncertain significance (May 16, 2023)2546581
7-18644773-G-T not specified Uncertain significance (Feb 06, 2023)3104646
7-18647822-C-T not specified Uncertain significance (Apr 17, 2023)2513960
7-18647877-G-A Likely benign (Dec 01, 2022)2657332
7-18647893-C-G not specified Uncertain significance (Mar 04, 2024)3104647
7-18647919-A-T not specified Benign (Mar 29, 2016)402926
7-18648516-T-G not specified Uncertain significance (Sep 14, 2022)2356942
7-18648550-G-A not specified Uncertain significance (Dec 22, 2023)3104648
7-18648621-C-G not specified Uncertain significance (May 07, 2024)3283717

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HDAC9protein_codingprotein_codingENST00000441542 25915468
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.0002681246620261246880.000104
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.064225590.7550.00002896906
Missense in Polyphen121239.670.504853034
Synonymous-0.01642112111.000.00001122057
Loss of Function6.32963.20.1420.00000354702

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001870.000187
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004640.0000464
European (Non-Finnish)0.0001600.000159
Middle Eastern0.000.00
South Asian0.00009810.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Represses MEF2-dependent transcription.;
Disease
DISEASE: Note=A chromosomal aberration involving HDAC9 is found in a family with Peters anomaly. Translocation t(1;7)(q41;p21) with TGFB2 resulting in lack of HDAC9 protein. {ECO:0000269|PubMed:12706107}.;
Pathway
Viral carcinogenesis - Homo sapiens (human);Alcoholism - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Valproic Acid Pathway, Pharmacodynamics;Pathway_PA165964473;MicroRNAs in cardiomyocyte hypertrophy;Neural Crest Differentiation;Cardiac Hypertrophic Response;Initiation of transcription and translation elongation at the HIV-1 LTR;VEGFA-VEGFR2 Signaling Pathway;Ethanol effects on histone modifications;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Disease;Signal Transduction;sumoylation by ranbp2 regulates transcriptional repression;signal dependent regulation of myogenesis by corepressor mitr;nfat and hypertrophy of the heart ;Signaling by NOTCH1;Signaling by NOTCH;TGF-beta super family signaling pathway canonical;Signaling events mediated by HDAC Class II;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Diseases of signal transduction;NOTCH1 Intracellular Domain Regulates Transcription (Consensus)

Recessive Scores

pRec
0.715

Intolerance Scores

loftool
0.306
rvis_EVS
-1.06
rvis_percentile_EVS
7.52

Haploinsufficiency Scores

pHI
0.933
hipred
Y
hipred_score
0.603
ghis
0.536

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.555

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hdac9
Phenotype
muscle phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
hdac9b
Affected structure
vascular lymphangioblast
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;response to amphetamine;inflammatory response;heart development;histone deacetylation;neuron differentiation;B cell differentiation;cellular response to insulin stimulus;peptidyl-lysine deacetylation;B cell activation;negative regulation of transcription, DNA-templated;regulation of skeletal muscle fiber development;regulation of striated muscle cell differentiation;histone H3 deacetylation;histone H4 deacetylation;positive regulation of cell migration involved in sprouting angiogenesis
Cellular component
histone deacetylase complex;nucleus;nucleoplasm;transcription factor complex;cytoplasm;histone methyltransferase complex
Molecular function
transcription corepressor activity;histone deacetylase activity;protein kinase C binding;protein binding;transcription factor binding;NAD-dependent histone deacetylase activity (H3-K14 specific);protein deacetylase activity;histone deacetylase binding;metal ion binding;repressing transcription factor binding